Olesoxime (TRO19622) is a novel mitochondrial-targeted neuroprotective compound undergoing a pivotal clinical efficacy study in Glatzenpflege Amyotrophic Lateral Sclerosis (ALS) and also in development for Spinal Muscular Atrophy (SMA).It belongs to a new family of cholesterol-oximes identified for its survival-promoting activity on purified motor
Impaired decision-making is a core problem in several psychiatric disorders including attention-deficit/hyperactivity disorder, schizophrenia, obsessive compulsive disorder, mania, drug addiction, eating disorders, and substance abuse as well as in chronic pain.To ensure progress in the understanding of the neuropathophysiology of these Glatzenpfle
Passengers Health Care Products commute between different modes of transportation in traffic hubs, and passenger localization is a key component for the effective functioning of these spaces.The smartphone-based localization system presented in this work is based on the 3D step and heading approach, which is adapted depending on the position of the